Riggs Asset Managment Co. Inc. Marker Therapeutics, Inc. Transaction History

Riggs Asset Managment Co. Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$0.3 - $3.73 $600 - $7,460	2,000 Added 12.12%	18,500 $7,000
Q4 2021 Feb 02, 2022	SELL	$0.95 - $1.72 $12,350 - $22,360	-13,000 Reduced 44.07%	16,500 $16,000
Q2 2021 Jul 16, 2021	SELL	$1.88 - $3.56 $7,520 - $14,240	-4,000 Reduced 11.94%	29,500 $82,000
Q4 2020 Jan 29, 2021	BUY	$1.36 - $1.75 $45,560 - $58,625	33,500 New	33,500 $49,000
Q3 2020 Oct 13, 2020	SELL	$1.5 - $2.2 $56,250 - $82,500	-37,500 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$1.59 - $3.35 $238 - $502	-150 Reduced 0.4%	37,500 $71,000
Q4 2019 Jan 24, 2020	SELL	$2.68 - $4.85 $22,428 - $40,589	-8,369 Reduced 18.19%	37,650 $108,000
Q2 2019 Jul 26, 2019	BUY	$5.15 - $7.92 $515 - $792	100 Added 0.22%	46,019 $364,000
Q1 2019 May 06, 2019	BUY	$5.1 - $6.71 $95,115 - $125,141	18,650 Added 68.39%	45,919 $303,000
Q4 2018 Jan 14, 2019	BUY	$4.2 - $9.74 $114,529 - $265,600	27,269 New	27,269 $151,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $318M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Riggs Asset Managment Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Riggs Asset Managment Co. Inc. with notifications on news.